TXG10x Genomics, Inc.
Price
+518%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, demanding price, growth steady, the market undecided.
Our mission is to accelerate the mastery of biology to advance human health. We are a life sciences technology company focused on building innovative products and solutions to interrogate, understand and master biology. Our integrated research solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across diverse disciplines including chemistry, biology, hardware and software.
In the company’s own words · 10-K filed Feb 13, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
10x Genomics, Inc. (TXG) reported revenue of $151M in Q2 2026 (quarter ended Jun 30, 2026), down 13% from the same quarter a year earlier. That came with a gross margin of 74% and net loss of $18M. For the full year FY2025, revenue was $643M (+5.2% year on year) and net income −$44M. Its largest product in Q2 2026 was Chromium Consumables at $88M, 56% of the disclosed total, well ahead of Spatial Consumables at 27%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 202610x Genomics Reports Second Quarter 2026 Financial Results.Earnings release · press release
- May 7, 202610x Genomics Reports First Quarter 2026 Financial Results.Earnings release · press release
- Jan 12, 202610x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $158.7MThe company’s own SEC segment disclosure.
- Chromium Consumables$88.5M56%
- Spatial Consumables$42.3M27%
- Service$10.7M7%
- Instruments$7.7M5%
- Spatial Instruments$4.6M3%
- Chromium Instruments$3.1M2%
- Other (1)$1.9M1%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Health Information Services
Ranks #16 of 20 by RyuScore